Today, diabetes is considered a growing global epidemic. In the diabetic environment, a large amount of reactive oxygen species are produced. This type of active oxygen causes severe damage to cell membranes, proteins, and DNA. Therefore, finding a solution to deal with and reduce this type of reactive oxygen is very important. One of the most effective ways to deal with oxidative damage and inflammation is the modulation of the nuclear factor erythroid 2 (Nrf2) signaling pathway. One of the useful natural substances that can be used for treatment in the signaling system is saffron. In this article, research evaluating the medicinal effects of saffron and its compounds and their mechanisms of action, especially the Nrf2 signaling pathway, have been investigated and studied. The results show that saffron and its components have the potential to treat diabetes due to their unique properties.
Get full access to this article
View all access options for this article.
References
1.
SunH, SaeediP, KarurangaS, et al.IDF diabetes atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract, 2022; 183:109119; doi: 10.1016/j.diabres.2021.109119
2.
SadeghiS, MahaniF, AmiriP, et al.Barriers toward the national program for prevention and control of diabetes in Iran: A qualitative exploration. Int J Health Policy Manag, 2023; 12(1):6908–6908; doi: 10.3417/2/ijhpm.2022.6908
DanemanD. Type 1 diabetes. Lancet, 2006; 367(9513):847–858; doi: 10.1016/S0140-6736(06)68341-4
5.
AshrafizadehM, AhmadiZ, FarkhondehT, et al.Autophagy as a molecular target of quercetin underlying its protective effects in human diseases. Arch Physiol Biochem, 2022; 128(1):200–208; doi: 10.1080/13813455.2019.1671458
6.
TalebiM, TalebiM, FarkhondehT, et al.An updated review on the versatile role of chrysin in neurological diseases: Chemistry, pharmacology, and drug delivery approaches. Biomed Pharmacother, 2021; 141:111906; doi: 10.1016/j.biopha.2021.111906
7.
KohandelZ, FarkhondehT, AschnerM, et al.Nrf2 a molecular therapeutic target for Astaxanthin. Biomed Pharmacother, 2021; 137:111374; doi: 10.1016/j.biopha.2021.111374
8.
TalebiM, TalebiM, FarkhondehT, et al.Molecular mechanism-based therapeutic properties of honey. Biomed Pharmacother, 2020; 130:110590; doi: 10.1016/j.biopha.2020.110590
9.
FarkhondehT, Pourbagher-ShahriAM, AshrafizadehM, et al.Green tea catechins inhibit microglial activation which prevents the development of neurological disorders. Neural Regen Res, 2020; 15(10):1792–1798; doi: 10.4103/1673-5374.280300
10.
OzougwuJC. The role of reactive oxygen species and antioxidants in oxidative stress. International Journal of Research, 2016; 3(6):1–8.
11.
Mirończuk-ChodakowskaI, WitkowskaAM, ZujkoME. Endogenous non-enzymatic antioxidants in the human body. Adv Med Sci, 2018; 63(1):68–78; doi: 10.1016/j.advms.2017.05.005
12.
SunC, LiuY, ZhanL, et al.Anti-diabetic effects of natural antioxidants from fruit. Trends in Food Science & Technology, 2021; 117:3–14; doi: 10.1016/j.tifs.2020.07.024
13.
RahaieeS, MoiniS, HashemiM, et al.Evaluation of antioxidant activities of bioactive compounds and various extracts obtained from saffron (Crocus sativus L.): A review. J Food Sci Technol, 2015; 52(4):1881–1888; doi: 10.1007/s13197-013-1238-x
14.
MustaffaF, IndurkarJ, AliN, et al.A review of Malaysian medicinal plants with potential antidiabetic activity. Journal of Pharmacy Research, 2011; 4(11):4217–4224.
15.
Sok YenF, Shu QinC, Tan Shi XuanS, et al.Hypoglycemic effects of plant flavonoids: A review. Evid Based Complement Alternat Med, 2021; 2021:2057333; doi: 10.1155/2021/2057333
16.
DehghanH, BidehM, SabetiAAM, et al.The effect of combined aerobic and resistance training on glycemic control and lipid profiles in type 2 diabetes patients: A randomized controlled trial. Diabetes Research and Clinical Practice, 2023.
17.
NandaS, MadanK. A comprehensive review on diabetes mellitus: A silent killer of 21st century. Heliyon, 2021; 7(2).
18.
ChristodoulouE, KadoglouNP, KostomitsopoulosN, et al.Experimental evidence for the anti-atherosclerotic potential of flavonoids: A systematic review of human and animal studies. J Pharm Pharmacol, 2015; 67(12):1634–1649.
19.
TossettaG, FantoneS, MontanariE, et al.Redox imbalance in testicular dysgenesis syndrome: The germ cell perspective. Antioxidants, 2022; 11(4):663; doi: 10.3390/antiox11040663
20.
TossettaG, FantoneS, MarzioniD, et al.Male fertility potential: The Astaxanthin promise. Cancers, 2023; 15(11):3037; doi: 10.3390/cancers15113037
21.
TossettaG, FantoneS, PianiF, et al.Redox dynamics and male fertility: Focus on the impact of nicotine and antioxidant molecules. Cells, 2023; 12(11):1545; doi: 10.3390/cells12111545
22.
BukkeVN, MoolaA, ServiddioG, et al.Role of oxidative stress and antioxidants in the pathogenesis of nonalcoholic fatty liver disease. World J Gastroenterol, 2022; 28(48):6909–6921; doi: 10.3748/wjg.v28.i48.6909
23.
Abdul-MuneerP. Ameliorative effect of dietary antioxidants on diabetes-induced mitochondrial dysfunction: An updated review. Journal of Integrative Neuroscience, 2023; 22(4):81.
Ashrafizadeh M, Ahmadi Z, Farkhondeh T, Samarghandian S. Autophagy as a molecular target of quercetin underlying its protective effects in human diseases. Arch Physiol Biochem 2022 Feb;128(1):200–208
26.
AhrazemO, Rubio-MoragaA, NebauerSG, et al.Saffron secondary metabolites production under abiotic stress: Inducing regulation and network analysis. J Agric Food Chem, 2015; 63(40):8751–8764.
27.
LeoneS, RecinellaL, ChiavaroliA, et al.Crocus sativus L.(Saffron): An updated review of experimental and clinical research. Phytotherapy Research, 2018; 32(12):2364–2375; doi: 10.1002/ptr.6181
28.
AhmadM, ZaffarG, MirSD, et al.Saffron: A natural gift for the management of diabetes mellitus. Research J of Medicinal Plant, 2011; 5(6):630–649; doi: 10.3923/rjmp.2011.630.649
29.
RiosJ, RecioM, GinerR, et al.An update review of saffron and its active constituents. Phytother Res, 1996; 10(3):189–193; doi: 10.1002/(SICI)1099-1573(199605)10:3<189::AID-PTR754>3.0.CO;2-C
30.
SaniA, TajikA, SeiiediSS, et al.The effects of saffron supplementation on clinical outcomes in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials. Nutr Metab Insights, 2022; 15:11786388221095223.
31.
AzgomiRN, KarimiA, ZarshenasMM, et al.A systematic review and meta-analysis of clinical trials on the effect of saffron on blood pressure, blood glucose, lipid profile, and body weight in people with metabolic syndrome. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2022; 16(1):102365.
32.
EbrahimzadehA, KaramianM, AbediF, et al.Saffron and its nano-formulations: A comprehensive review on biomedical applications. Advances in Materials Science and Engineering, 2023; 2023(1):1878170.
33.
EbrahimzadehA, KaramianM, AlemzadehE, et al.Saffron and its constituents as modulators of inflammatory pathways in the management of diabetes and its complications. Biomass Conversion and Biorefinery, 2023; 1–12.
34.
AlemzadehE, KaramianM, AbediF, et al.Saffron and its active ingredients: Promising modulators in the control of metabolic syndrome components and related disorders. Acta Tropica, 2022; 228:106325; doi: 10.1016/j.actatropica.2022.106325
35.
SaveSS, RachineniK, HosurRV, et al.Evaluation of structural and antioxidant properties of glycosylated saffron carotenoids. Int J Biol Macromol, 2019; 141:585–595.
36.
CarmonaM, ZalacainA, SánchezAM, et al.HPLC-PDAD-MS determination of phenolic compounds in saffron. J Agric Food Chem, 2006; 54(3):973–979.
37.
SepahiS, GolfakhrabadiM, BonakdaranS, et al.Saffron supplementation improves antioxidant status and mental health and reduces body fat in obese or overweight individuals: A randomized, double-blind, placebo-controlled trial. Clin Nutr ESPEN, 2022; 50:255–263; doi: 10.1016/j.clnesp.2022.05.006
38.
XueM, QianQ, AdaikalakoteswariA, et al.Activation of receptor for advanced glycation end products induces renal inflammation and microvascular permeability. Diabetes, 2008; 57(10):2809–2817; doi: 10.2337/db06-1003
39.
ShafieeM, Aghili MoghaddamNS, NosratiM, et al.Effects of saffron consumption on serum lipids, glycemia, and body weight in type 2 diabetes mellitus: A randomized controlled trial. J Agric Food Chem, 2017; 65(50):10837–10843.
40.
BairdL, Dinkova-KostovaAT. The cytoprotective role of the Keap1-Nrf2 pathway. Arch Toxicol, 2011; 85(4):241–272; doi: 10.1007/s00204-011-0674-5
41.
TurpaevK. Reactive oxygen species and regulation of gene expression. Biochemistry Moscow, 2013; 78(2):111–126; doi: 10.1134/S0006297913020016
42.
PetricD. Saffron in neurodegenerative diseases: An update. Planta Med, 2018; 85(1):24–31.
43.
BejE, VolpeAR, CesareP, et al.Saffron supplementation modulates cellular senescence and redox balance in human adipocytes: Focus on healthy aging. Phytother Res, 2024; 38(5):2482–2495.
44.
ElgazarAF, RezqAA, BukhariHM. Protective effect of saffron extract on Streptozotocin-induced diabetic encephalopathy in rats. Eur J Biol Sci, 2013; 5(1):14–22.
45.
KimM, JeeS-C, KimK-S, et al.Nrf2 signaling regulates cellular senescence in diabetes and aging. Antioxidants, 2021; 10(5):787; doi: 10.3390/antiox10050787
46.
GerritsEG, AlkhalafA, LandmanGWD, et al.Influence of glucose fluctuations on microvascular function in type 2 diabetes mellitus. PLoS One, 2014; 9(2):e89719; doi: 10.1371/journal.pone.0089719
47.
XuZ, WeiY, GongJ, et al.Advanced glycation end product receptor (AGER) deficiency protects against nephropathy in diabetic mice. Diabetologia, 2014; 57(1):204–213; doi: 10.1007/s00125-013-3093-8
48.
MarroneG, UrciuoliS, Di LauroM, et al.Saffron for mental health: An umbrella review and critical appraisal of meta-analyses. Nutrients, 2024; 16(14).
49.
KianbakhtS, HajiaghaeeR. Anti-hyperglycemic effect of saffron (Crocus sativus L.) in streptozotocin-induced diabetic rats. J Med Plants, 2011; 10(39):82–89.
50.
Cerdá-BernadD, Valero-CasesE, PastorJJ, et al.Health effects of Crocetin and Crocin from saffron: A systematic review and meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutr, 2022; 62(12):3232–3249.
51.
HashemiM, HosseinzadehH. The effect of saffron in treatment of Alzheimer’s disease: An updated meta-analysis. Food Chem Toxicol, 2019; 130:44–60.
52.
MengL, CuiL. Chemistry and biology of saffron. Arch Pharm Res, 2008; 31:357–363.
53.
MoshiriM, VahabzadehM, HosseinzadehH. Clinical applications of saffron in the treatment of depression. Drug Research, 2015; 65(6):287–295.
54.
FarkhondehT, SamarghandianS. The neuroprotective effects of saffron: A review. Asian Journal of Pharmaceutical and Clinical Research, 2014; 8(20):541–549.
55.
Varasteh AR, VahediF, SankianM, et al.Specific IgG antibodies (total and subclasses) against Saffron pollen: a study of their correlation with specific IgE and immediate skin reactions. Iranian Journal of Allergy, Asthma and Immunology, 2007; 6:189–195.
56.
MotohashiH, O’ConnorT, KatsuokaF, et al.Integration and diversity in the regulation of gene expression by Maf factors. Gene, 2002; 294(1–2):1–12; doi: 10.1016/s0378-1119(02)00788-6
57.
HayesJD, Dinkova-KostovaAT. The Nrf2 regulatory network provides an interface between redox and intermediary metabolism. Trends Biochem Sci, 2014; 39(4):199–218; doi: 10.1016/j.tibs.2014.02.002
58.
NguyenT, NioiP, PickettCB. The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress. J Biol Chem, 2009; 284(20):13291–13295; doi: 10.1074/jbc.R900010200
EbrahimiF, SahebkarA, AryaeianN, et al.Effects of saffron supplementation on inflammation, oxidative stress, and clinical outcomes in non-alcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials. Diabetes Metab Syndr Obes Targets Ther, 2019:2107–2115.
62.
BanskotaS, BrimH, KwonYH, et al.Saffron and its major ingredients: Apoptosis induction and therapeutic potentials in cancer. Molecules, 2021; 26(11):3351; doi: 10.3390/molecules26113351
63.
AsbaghiO, SoltaniS, NorouziN, et al.The effect of saffron supplementation on mental health and metabolic profile in adults: A systematic review and meta-analysis of randomized controlled trials. Complement Ther Med, 2019; 47:102158.
64.
ElfardiYR, El BoukhariR, FatimiA, et al.Saffron-Based therapies for metabolic syndrome: An up-to-date review. Drugs Drug Candidates, 2024; 3(3):437–454.
DolgachevaLP, ZinchenkoVP, GoncharovNV. Role of Nrf2 in regulation of Cardiocyte redox status in diabetes mellitus. Int J Mol Sci, 2022; 23(21):13043.
67.
DayalanNaidu S, AT.Dinkova-Kostova. KEAP1, a cysteine-based sensor and a drug target for the prevention and treatment of chronic disease. Open Biol 2020 Jun;10(6):200105. doi: 10.1098/rsob.200105
68.
MatzingerM, FischhuberK, HeissEH. Redox signaling as a molecular switchboard: How cells integrate oxidative stress responses with metabolic pathways. Biotechnol Adv, 2018; 36(6):1738–1767.
69.
MotaghinejadM, MotevalianM, SuredaA. The potential effect of saffron on neurological disorders: Focusing on neurodegenerative diseases and psychiatric disorders. Acta Neurobiol Exp (Wars), 2024; 84(1):59–69.
70.
Jiménez-OsorioAS, PicazoA, González-ReyesS, et al.Protective effect of different antioxidants against paraquat-induced mitochondrial dysfunction and oxidative stress in SH-SY5Y Cells. Int J Mol Sci, 2014; 15(11):20290–20305.
71.
AmriJ, AlaeeM, LatifiSA, et al.The effect of saffron supplementation on blood glucose and lipid profile in patients with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials. Horm Mol Biol Clin Investig, 2021; 42(4):411–418.
72.
ManciniA, Serrano-DíazJ, NavaE, et al.RAGE deletion protects against experimental AAA progression through decreased inflammation and oxidative stress. J Vasc Res, 2014; 51(5):393–404; doi: 10.1159/000368930
73.
KhoshandamA, RazaviBM, HosseinzadehH. A review of the effects of Crocus sativus (saffron) and its constituents on nervous system disorders. Iran J Basic Med Sci, 2022; 25(7):789.
74.
BajpaiVK, AlamMB, QuanKT, et al.Crocin from Gardenia jasminoides Ellis displays anti-inflammatory and anti-oxidative stress potential in intestinal epithelial cells. Sci Rep, 2017; 7:46035.
75.
MirRA, TyagiA, HussainSJ, et al.Decoding the multifaceted role of crocin in attenuating neurological maladies: A comprehensive review. Plants (Basel), 2024; 13(11).
76.
SamarghandianS, Azimi-NezhadM, FarkhondehT. Influence of saffron on expression of SIRT1, PPARγ and UCP2 genes in Streptozotocin-Induced diabetic rats. Indian Heart J, 2017; 69(2):151–159.
77.
HamedaniSGolpour-, PourmasoumiM, ZarifiSH, et al.Effects of saffron supplementation on glycemic control, lipid profile, and oxidative stress parameters in subjects with type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials. Heliyon, 2024; 10(2):e24334; doi: 10.1016/j.heliyon.2024.e24334
78.
EfentakisP, RizakouA, ChristodoulouE, et al.The effect of flavonoids on endothelial function assessed by flow-mediated dilatation: A systematic review and meta-analysis. Nutr Metab Cardiovasc Dis, 2017; 27(10):919–929.
79.
Moravej AlealiA, AmaniR, ShahbazianH, et al.Effects of saffron supplementation on glycemic indices, blood pressure, and serum lipid concentrations in overweight or obese patients with prediabetes: A randomized double-blind controlled trial. Phytother Res, 2019; 33(6):1648–1657.
80.
JazaniAM, KarimiA, AzgomiRND. Efficacy of saffron in treatment of mild-to-moderate depression compared to fluoxetine: A meta-analysis. Clinical Nutrition ESPEN, 2022; 48:148–157.
81.
Rodriguez-RuizV, BarzegariA, ZuluagaM, et al.Bioaccessibility and antioxidant activity of carotenoids and polyphenols from saffron (Crocus sativus L.) styles. J Funct Foods, 2016; 26:123–134.
82.
AzimiP, GhiasvandR, FeiziA, et al.Effect of cinnamon supplementation on blood pressure in adults: A systematic review and meta-analysis of randomized controlled trials. Blood Press, 2016; 25(3):133–140; doi: 10.3109/08037051.2015.1111020
83.
XiaoF, SongY, WangG, et al.The role of saffron and its active components in tumor therapy: A review. Pharmaceuticals, 2024; 17(7):843; doi: 10.3390/ph17070843
84.
DograA, KotwalP, GourA, et al.Crocin inhibits advanced glycation end products (AGEs)-induced retinal pericyte apoptosis via modulation of ERK/MAPK signaling pathway. ACS Omega, 2020; 5(17):9885–9891; doi: 10.1021/acsomega.0c00160
85.
SaadatS, GhasemiZ, MemarziaA, et al.Ameliorative effects of saffron on the development of contrast-induced nephropathy through reduction of oxidative stress and inflammation in a rat model. Iran J Basic Med Sci, 2024; 27(4):391.
86.
DaiL, ChenL, WangW. Saffron for treatment of depression: A meta-analysis of randomized controlled trials. J Nerv Ment Dis, 2020; 208(4):269–276; doi: 10.1097/NMD.0000000000001118
87.
NaghizadehB, BoroushakiMT, VahdatiMN, et al.Protective effects of crocin against cisplatin-induced acute renal failure and oxidative stress in rats. Iranian Biomedical Journal, 2008; 12(2):93–100.
88.
RahimanN, AkaberiM, SahebkarA, et al.Saffron in metabolic syndrome: A systematic review and meta-analysis of randomized controlled trials. Microvasc Res, 2018; 118:82–89.
89.
RadmehrV, AhangarpourA, MardSA, et al.The effect of hydro-alcoholic extract of Crocus sativus L. (saffron) on biochemical parameters and liver tissue in streptozotocin-induced diabetic rats. Iran J Basic Med Sci, 2022; 25(2):179.
90.
ZhangJ, ZhaoX, ZhuH, et al.Crocin attenuates diabetic cardiomyopathy by inhibiting oxidative stress and inflammation via the Nrf2/HO-1 signaling pathway. Iran J Basic Med Sci, 2022; 25(2):193.
91.
RadmehrV, AhangarpourA, MardSA, et al.Ameliorative effects of Crocus sativus L. (saffron) on kidney tissue damage in streptozotocin-induced diabetic rats. Iran J Basic Med Sci, 2022; 25(11):1341.
92.
QiuY, JiangX, LiuD, et al.Crocin improves insulin resistance and pancreatic β-cell dysfunction in a rat model of type 2 diabetes mellitus via activation of the PI3K/Akt/GSK-3β signaling pathway. Front Pharmacol, 2020; 11:541.
93.
AsaiA, NakanoT, TakahashiM, et al.Degradation of dietary carotenoids during gastrointestinal digestion and absorption. J Agric Food Chem, 2005; 53(18):7302–7306.
94.
SamarghandianS, BorjiA, DelkhoshMB, et al.Effect of saffron aqueous extract on fetal malformation in streptozotocin-induced diabetic rats. J Pharm Pharm Sci, 2013; 16(2):352–362; doi: 10.1843/3/j3zs3q
95.
GuptaM, WaniA, AhsanAU, et al.Crocin mitigates doxorubicin-induced cardiotoxicity by modulating oxidative stress, inflammation, and apoptosis in H9c2 cells. Toxicol Appl Pharmacol, 2021; 423:115582.
96.
MahdiFA, ZalzalaMH. Effect of saffron on some biochemical parameters in type 2 diabetic patients. Iraqi J Pharm Sci, 2021; 30:196–203.
97.
YangL, QianZ, JiH, et al.Saffron extract protects heart against ischemia/reperfusion injury in rats via inhibiting oxidative stress and apoptosis. Eur J Pharmacol, 2010; 642(1–3):47–55.
98.
WenYL, HeZ, HouDX, et al.Redox regulation of autophagy in diabetic cardiomyopathy. Oxid Med Cell Longev, 2021; 2021:1–18.
99.
XuZ, LinS, GongJ, et al.Receptor for advanced glycation end products in cardiovascular and metabolic diseases: Pathogenesis and therapeutic implications. Front Med (Lausanne), 2021; 8:681391.
100.
CaoW, CuiJ, LiS, et al.Crocin prevents palmitate-induced apoptosis in mouse podocytes by reducing endoplasmic reticulum stress and activating autophagy. Life Sci, 2017; 181:9–16.
101.
YangM, MaoG, OuyangL, et al.Crocin protects against high glucose-induced injury in human umbilical vein endothelial cells by activating the Nrf2/HO-1 signaling pathway. Mol Med Rep, 2020; 21(2):641–648.
102.
XiL, QianZ, XuG, et al.Inhibitory effect of crocin on glucose-induced retinal pericyte apoptosis in vitro. J Nutr Biochem, 2007; 18(1):64–72.
103.
ManhasD, DhimanS, KourH, et al.Unveiling the therapeutic potential of Crocus sativus L. (Saffron) stigma extracts and their bioactive constituent, Crocin, on oral cancer cells: an in vitro study. ACS Omega, 2024; 9(19):21494–21509; doi: 10.1021/acsomega.4c02116
104.
GuoZL, LiMX, LiXL, et al.Crocin alleviates cognitive impairment in a rat model of vascular dementia by inhibiting neuroinflammation and oxidative stress via the Nrf2/HO-1 signaling pathway. Front Pharmacol, 2022; 12:745683.
105.
AliA, YuL, KousarS, et al.Unveiling the Pharmacological Potential of Crocin: A comprehensive review of its therapeutic advances. Front Nutr, 2022; 9:1009807.
106.
GhaffariS, RoshanravanN. The effects of saffron supplementation on liver enzymes, glycemic control, and lipid profile in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis. Biomed Pharmacother, 2019; 109:21–27.
107.
AhrazemO, LópezAJ, ArgandoñaJ, et al.Transcriptomic analysis reveals the molecular mechanisms underlying the response of saffron plants to water deficit. Sci Rep, 2020; 10(1):552.
108.
ChristodoulouE, GrafakouME, SkaltsaE, et al.The effect of flavonoids on markers of oxidative stress and endothelial function in patients with type 2 diabetes mellitus: A randomised controlled trial. J Pharm Pharmacol, 2019; 71(5):753–764.
109.
MirhadiE, NassirliH, Malaekeh-NikoueiB. Saffron extract ameliorates retinal oxidative stress and apoptosis in Streptozotocin-Induced diabetic rats. J Pharm Investig, 2020; 50(1):47–58.
110.
BootsAW, HaenenGR, BastA. Health effects of quercetin: From antioxidant to nutraceutical. Eur J Pharmacol, 2008; 585(2–3):325–337; doi: 10.1016/j.ejphar.2008.03.008
111.
DingT, WangS, ZhangX, et al.Crocin protects against high glucose-induced endothelial dysfunction via the upregulation of SIRT1 expression. Phytomedicine, 2018; 41:45–53; doi: 10.1016/j.phymed.2018.01.026
112.
DongB, ShiZ, DongY, et al.Crocin alleviates diabetic cardiomyopathy by inhibiting ferroptosis through the Nrf2/HO-1 signaling pathway. Biomed Pharmacother, 2022; 151:113108.
113.
EbrahimpourS, ShahidiSB, AbbasiM, et al.The effects of saffron supplementation on blood pressure, lipid profile, and blood glucose in individuals with metabolic syndrome: A systematic review and meta-analysis of randomized controlled trials. Sci Rep, 2020; 10(1):15957.
114.
LiuYW, LiuXL, KongL, et al.Crocin improves cognitive deficits and hippocampal synaptic plasticity in streptozotocin-induced diabetic mice. Biomed Pharmacother, 2019; 109:2145–2154.
115.
TanigawaS, FujiiM, HouDX. Action of crocin on glucose metabolism in streptozotocin-induced diabetic mice. Free Radic Biol Med, 2007; 42(11):1690–1703.
116.
YuC, XiaoJH. Role of Nrf2 in regulating the pathogenesis of diabetic cardiomyopathy. Oxid Med Cell Longev, 2021; 2021:6635460.
117.
LuoX, WengX, BaoX, et al.Crocin improves cognitive impairment via regulating gut microbiota and inhibiting NLRP3 inflammasome activation in APP/PS1 mice. Redox Biol, 2022; 57:102511.
118.
KandpalA, KumarK, SinghS, et al.Unveiling the therapeutic promise of crocin: A comprehensive review of its cardiovascular implications. Cardiovasc Drugs Ther, 2024:1–16.
119.
TangH, WenJ, QinT, et al.Crocin alleviates pyroptosis and inflammation in diabetic cardiomyopathy via regulating miR-223-3p/TXNIP axis. Front Cell Neurosci, 2023; 17:1228761.
120.
ZhangL, WangX, ChangL, et al.Crocin Ameliorates Gentamicin-Induced renal tubular cell pyroptosis and renal fibrosis by activating the Nrf2/HO-1 signaling pathway. Ren Fail, 2024; 46(1):2327495.
121.
YiM, Cruz CisnerosL, ChoEJ, et al.Crocetin as a promising bioactive compound for diabetes mellitus and its complications. Int J Mol Sci, 2024; 25(2):821.
122.
ZhangL, XuLY, TangF, et al.Crocin protects against high glucose-induced podocyte injury by inhibiting endoplasmic reticulum stress via the PERK/eIF2α/ATF4 pathway. J Pharm Anal, 2024; 14(6):100930.
